Four measures of treatment compliance among patients recovering from psychotic episodes - A comparative study;Cztery miary przestrzegania zaleceń u chorych po przebytym epizodzie psychotycznym - Porównanie

Psychiatria Polska

Volumn 47, Issue 5, 2013, Pages 759-773

  Friemann, Karolina ^a   Wciórka, Jacek ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Compliance adherence; Measures; Psychosis

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICIAN RATING OF COMPLIANCE SCALE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DRUG ATTITUDE INVENTORY 10; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ADHERENCE RATING SCALE; MEDICATION COMPLIANCE; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT RATING OF COMPLIANCE SCALE; PREDICTIVE VALUE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; REMISSION; SCORING SYSTEM; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84885146339     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: 10.12740/pp/18341     Document Type: Article

References (14)

1. Friemann K. i Wciórka J. Compliance - przezytek czy termin uzyteczny. Post Psychiatr Neurol 2008, 17(4): 367-375.
2. Friemann K. i Wciórka J. Dostepne metody badania przestrzegania zaleceń farmakoterapeutycznych w leczeniu psychoz. Post Psychiatr Neurol 2009; 18(2): 169-181.
3. Velligan D, Sajatovic M, Valenstein M., Riley W T, Safren S, Lewis- Fernandez R, Weiden P, Ogdegbe G, Jamison J. Methodological challenges in psychiatric treatment adherence research. Clinical Schizophrenia & Related Psychoses 2010; 74-91.
4. Velligan DI, Weiden PJ. Interventions to Improve Adherence to Antipsychotic Medications. Psychiatric Times 2006; 23 (9).
5. Velligan D I, Lam YF, Glahn D C, Barrett J A, Maples N J, Ereshefsky L, Miller A L.. Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature. Schizophr Bull 2006; 32(4): 724-742.
6. American Psychiatric Association. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC; 2000.
7. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Act Psychiatr Scand 1987; Suppl 334: 1-100.
8. Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. 18-month follow-up. Brit J Psychiatry 1998;172: 413-419.
9. Hogan TP, Awad AG, Eastwood R. A self-reported scale predictive of drug compliance in schizophrenia, reliability and discriminative validity. Psychological Med 1983; 13(1): 177-183.
10. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research 2000; 42: 241-247.
11. Rabinovitch M, Béchard-Evans L, Schmitz N, Joober R, Malla A. Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis. Canad J Psychiatry. 2009; 54(1): 28-35.
12. Acosta FJ, Bosch E, Sarmiento G, Juanes N, Caballero-Hidalgo A, Mayans T. Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables. Schizophr Research. 2009;107(2-3): 213-217.
13. Byerly MJ, Thompson A, Carmody T, Bugno R, Erwin T, Kashner M, Rush AJ. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatric Serv 2007; 58(6): 844-847.
14. Czernikiewicz A. Psychoedukacja w schizofrenii. W: Meder J, Sawicka M (red) Psychoterapia schizofrenii. Kraków; 2006, s. 115-116.